Ipilimumab
Products Ipilimumab is commercially available as a concentrate for the preparation of an infusion solution (Yervoy). It has been approved in many countries since 2011. Structure and properties Ipilimumab is a recombinant, humanized monoclonal antibody with an approximate molecular weight of 148 kDa. It is an IgG1-kappa immunoglobulin (IgG1κ). Effects Ipilimumab (ATC L01XC11) has indirect … Ipilimumab
